Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 2353560, 11 pages
http://dx.doi.org/10.1155/2016/2353560
Research Article

The Dysregulation of Polyamine Metabolism in Colorectal Cancer Is Associated with Overexpression of c-Myc and C/EBPβ rather than Enterotoxigenic Bacteroides fragilis Infection

1Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow 119991, Russia
2Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow 119121, Russia
3National Medical Research Center of Radiology, Ministry of Healthcare of the Russian Federation, Moscow 125284, Russia
4Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow 117997, Russia

Received 11 December 2015; Revised 28 March 2016; Accepted 27 April 2016

Academic Editor: Birke Bartosch

Copyright © 2016 Anastasiya V. Snezhkina et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. A. Torre, F. Bray, R. L. Siegel, J. Ferlay, J. Lortet-Tieulent, and A. Jemal, “Global cancer statistics, 2012,” CA: A Cancer Journal for Clinicians, vol. 65, no. 2, pp. 87–108, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. F. A. Haggar and R. P. Boushey, “Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors,” Clinics in Colon and Rectal Surgery, vol. 22, no. 4, pp. 191–197, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. I. Maclennan and J. Hill, “How can doctors diagnose colorectal cancer earlier?” British Medical Journal, vol. 306, no. 6894, p. 1707, 1993. View at Publisher · View at Google Scholar · View at Scopus
  4. B. A. Kohler, R. L. Sherman, N. Howlader et al., “Annual report to the nation on the status of cancer, 1975–2011, featuring incidence of breast cancer subtypes by race/ethnicity, poverty, and state,” Journal of the National Cancer Institute, vol. 107, no. 6, Article ID djv048, 2015. View at Publisher · View at Google Scholar
  5. S. Maffei, A. Colantoni, S. Kaleci, P. Benatti, E. Tesini, and M. P. de Leon, “Clinical features of colorectal cancer patients in advanced age: a population-based approach,” Internal and Emergency Medicine, vol. 11, no. 2, pp. 191–197, 2016. View at Publisher · View at Google Scholar · View at Scopus
  6. C. B. Aarons, S. Shanmugan, and J. I. S. Bleier, “Management of malignant colon polyps: current status and controversies,” World Journal of Gastroenterology, vol. 20, no. 43, pp. 16178–16183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. V. Stigliano, L. Sanchez-Mete, A. Martayan, and M. Anti, “Early-onset colorectal cancer: a sporadic or inherited disease?” World Journal of Gastroenterology, vol. 20, no. 35, pp. 12420–12430, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. L. L. Strate and S. Syngal, “Hereditary colorectal cancer syndromes,” Cancer Causes and Control, vol. 16, no. 3, pp. 201–213, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. A. Brewer, E. L. Bokey, C. Fung, and P. H. Chapuis, “Heredity, molecular genetics and colorectal cancer: a review,” Australian and New Zealand Journal of Surgery, vol. 63, no. 2, pp. 87–94, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Chen, G. Xia, C. Zhang, and Y. Sun, “Correlation between smoking history and molecular pathways in sporadic colorectal cancer: a meta-analysis,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 3, pp. 3241–3257, 2015. View at Google Scholar · View at Scopus
  11. Y. Park, D. J. Hunter, D. Spiegelman et al., “Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies,” Journal of the American Medical Association, vol. 294, no. 22, pp. 2849–2857, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. H. Akin and N. Tözün, “Diet, microbiota, and colorectal cancer,” Journal of Clinical Gastroenterology, vol. 48, supplement 1, pp. S67–S69, 2014. View at Publisher · View at Google Scholar
  13. R. F. Tayyem, I. N. Shehadeh, S. S. AbuMweis et al., “Physical inactivity, water intake and constipation as risk factors for colorectal cancer among adults in Jordan,” Asian Pacific Journal of Cancer Prevention, vol. 14, no. 9, pp. 5207–5212, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Yashiro, “Ulcerative colitis-associated colorectal cancer,” World Journal of Gastroenterology, vol. 20, no. 44, pp. 16389–16397, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. J. K. Dyson and M. D. Rutter, “Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?” World Journal of Gastroenterology, vol. 18, no. 29, pp. 3839–3848, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. S. K. Nayudu and B. Balar, “Colorectal cancer screening in human immunodeficiency virus population: are they at average risk?” World Journal of Gastrointestinal Oncology, vol. 4, no. 12, pp. 259–264, 2012. View at Publisher · View at Google Scholar
  17. F. Tafvizi, Z. T. Fard, and R. Assareh, “Epstein-Barr virus DNA in colorectal carcinoma in Iranian patients,” Polish Journal of Pathology, vol. 66, no. 2, pp. 154–160, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Beral, E. Banks, G. Reeves, and P. Appleby, “Use of HRT and the subsequent risk of cancer,” Journal of Epidemiology and Biostatistics, vol. 4, no. 3, pp. 191–210, 1999. View at Google Scholar · View at Scopus
  19. M. Bonnet, E. Buc, P. Sauvanet et al., “Colonization of the human gut by E. coli and colorectal cancer risk,” Clinical Cancer Research, vol. 20, no. 4, pp. 859–867, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Goodwin, C. E. Destefano Shields, S. Wu et al., “Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilis-induced colon tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 37, pp. 15354–15359, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Boleij, E. M. Hechenbleikner, A. C. Goodwin et al., “The bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients,” Clinical Infectious Diseases, vol. 60, no. 2, pp. 208–215, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Vujcic, P. Diegelman, C. J. Bacchi, D. L. Kramer, and C. W. Porter, “Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin,” Biochemical Journal, vol. 367, no. 3, pp. 665–675, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. R. Chaturvedi, T. de Sablet, R. M. Peek, and K. T. Wilson, “Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk,” Gut microbes, vol. 3, no. 1, pp. 48–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. R. Chaturvedi, T. de Sablet, M. Asim et al., “Increased Helicobacter pylori-associated gastric cancer risk in the Andean region of Colombia is mediated by spermine oxidase,” Oncogene, vol. 34, no. 26, pp. 3429–3440, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Mittal, M. R. Siddiqui, K. Tran, S. P. Reddy, and A. B. Malik, “Reactive oxygen species in inflammation and tissue injury,” Antioxidants and Redox Signaling, vol. 20, no. 7, pp. 1126–1167, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Van Zuylen, J. Bridgewater, A. Sparreboom et al., “Phase I and pharmacokinetic study of the polyamine synthesis inhibitor SAM486A in combination with 5-fluorouracil/leucovorin in metastatic colorectal cancer,” Clinical Cancer Research, vol. 10, no. 6, pp. 1949–1955, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. W. L. Allen, E. G. McLean, J. Boyer et al., “The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells,” Molecular Cancer Therapeutics, vol. 6, no. 1, pp. 128–137, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Pledgie, Y. Huang, A. Hacker et al., “Spermine oxidase SMO(PAOh1), not N1-acetylpolyamine oxidase PAO, is the primary source of cytotoxic H2O2 in polyamine analogue-treated human breast cancer cell lines,” The Journal of Biological Chemistry, vol. 280, no. 48, pp. 39843–39851, 2005. View at Publisher · View at Google Scholar · View at Scopus
  29. A. Pledgie-Tracy, M. Billam, A. Hacker et al., “The role of the Polyamine catabolic enzymes SSAT and SMO In the synergistic effects of standard chemotherapeutic agents with a Polyamine analogue In human breast cancer cell lines,” Cancer Chemotherapy and Pharmacology, vol. 65, no. 6, pp. 1067–1081, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. A. R. Mank-Seymour, T. R. Murray, K. A. Berkey, L. Xiao, S. Kern, and R. A. Casero Jr., “Two active copies of the X-linked gene spermidine/spermine N1-acetyltransferase (SSAT) in a female lung cancer cell line are associated with an increase in sensitivity to an antitumor polyamine analogue,” Clinical Cancer Research, vol. 4, no. 8, pp. 2003–2008, 1998. View at Google Scholar · View at Scopus
  31. D. M. Hari, A. M. Leung, J.-H. Lee et al., “AJCC cancer staging manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?” Journal of the American College of Surgeons, vol. 217, no. 2, pp. 181–190, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. S. Viljoen, A. Dakshinamurthy, P. Goldberg, and J. M. Blackburn, “Quantitative profiling of colorectal cancer-associated bacteria reveals associations between Fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer,” PLoS ONE, vol. 10, no. 3, Article ID e0119462, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. M. S. Fedorova, A. V. Kudryavtseva, V. A. Lakunina et al., “Downregulation of OGDHL expression is associated with promoter hypermethylation in colorectal cancer,” Molecular Biology, vol. 49, no. 4, pp. 608–617, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. V. N. Senchenko, E. A. Anedchenko, T. T. Kondratieva et al., “Simultaneous down-regulation of tumor suppressor genes RBSP3/CTDSPL, NPRL2/G21 and RASSF1A in primary non-small cell lung cancer,” BMC Cancer, vol. 10, article 75, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. G. S. Krasnov, N. I. Oparina, A. A. Dmitriev et al., “Novel reference gene RPN1 for normalization of quantitative data in lung and kidney cancer,” Molekuliarnaia Biologiia, vol. 45, no. 2, pp. 238–248, 2011. View at Google Scholar · View at Scopus
  36. J. Doležel, J. Bartoš, H. Voglmayr, J. Greilhuber, and R. A. Thomas, “Nuclear DNA content and genome size of trout and human,” Cytometry Part: A, vol. 51, no. 2, pp. 127–129, 2003. View at Google Scholar · View at Scopus
  37. V. N. Senchenko, G. S. Krasnov, A. A. Dmitriev et al., “Differential expression of CHL1 Gene during development of major human cancers,” PLoS ONE, vol. 6, no. 3, Article ID e15612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. G. S. Krasnov, A. A. Dmitriev, N. V. Melnikova et al., “CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms,” Nucleic Acids Research, vol. 44, no. 7, article e62, 2016. View at Publisher · View at Google Scholar
  39. W. E. C. Moore, E. P. Cato, and L. V. Holdeman, “Some current concepts in intestinal bacteriology,” American Journal of Clinical Nutrition, vol. 31, no. 10, pp. S33–S42, 1978. View at Google Scholar · View at Scopus
  40. C. L. Sears, A. L. Geis, and F. Housseau, “Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis,” The Journal of Clinical Investigation, vol. 124, no. 10, pp. 4166–4172, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. C. L. Sears, S. Islam, A. Saha et al., “Association of enterotoxigenic Bacteroides fragilis infection with inflammatory diarrhea,” Clinical Infectious Diseases, vol. 47, no. 6, pp. 797–803, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. E. C. Wick and C. L. Sears, “Bacteroides spp. and diarrhea,” Current Opinion in Infectious Diseases, vol. 23, no. 5, pp. 470–474, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Swidsinski, J. Weber, V. Loening-Baucke, L. P. Hale, and H. Lochs, “Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease,” Journal of Clinical Microbiology, vol. 43, no. 7, pp. 3380–3389, 2005. View at Publisher · View at Google Scholar · View at Scopus
  44. F. Housseau and C. L. Sears, “Enterotoxigenic Bacteroides fragilis (ETBF)-mediated colitis in Min (Apc+/−) mice: a human commensal-based murine model of colon carcinogenesis,” Cell Cycle, vol. 9, no. 1, pp. 3–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Wu, J. Shin, G. Zhang, M. Cohen, A. Franco, and C. L. Sears, “The Bacteroides fragilis toxin binds to a specific intestinal epithelial cell receptor,” Infection and Immunity, vol. 74, no. 9, pp. 5382–5390, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. C. L. Sears, “Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes,” Clinical Microbiology Reviews, vol. 22, no. 2, pp. 349–369, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. S. Wu, K.-C. Lim, J. Huang, R. F. Saidi, and C. L. Sears, “Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 25, pp. 14979–14984, 1998. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Wu, K.-J. Rhee, M. Zhang, A. Franco, and C. L. Sears, “Bacteroides fragilis toxin stimulates intestinal epithelial cell shedding and γ-secretase-dependent E-cadherin cleavage,” Journal of Cell Science, vol. 120, part 11, pp. 1944–1952, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. J. M. David and A. K. Rajasekaran, “Dishonorable discharge: the oncogenic roles of cleaved e-cadherin fragments,” Cancer Research, vol. 72, no. 12, pp. 2917–2923, 2012. View at Publisher · View at Google Scholar · View at Scopus
  50. J. M. Kim, S. J. Cho, Y.-K. Oh, H.-Y. Jung, Y.-J. Kim, and N. Kim, “Nuclear factor-kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin,” Clinical and Experimental Immunology, vol. 130, no. 1, pp. 59–66, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Kim, H. Y. Jung, J. Y. Lee, J. Youn, C.-H. Lee, and K.-H. Kim, “Mitogen-activated protein kinase and activator protein-1 dependent signals are essential for Bacteroides fragilis enterotoxin-induced enteritis,” European Journal of Immunology, vol. 35, no. 9, pp. 2648–2657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Wu, J. Powell, N. Mathioudakis, S. Kane, E. Fernandez, and C. L. Sears, “Bacteroides fragilis enterotoxin induces intestinal epithelial cell secretion of interleukin-8 through mitogen-activated protein kinases and a tyrosine kinase-regulated nuclear factor-κB pathway,” Infection and Immunity, vol. 72, no. 10, pp. 5832–5839, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Wu, P. J. Morin, D. Maouyo, and C. L. Sears, “Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation,” Gastroenterology, vol. 124, no. 2, pp. 392–400, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. S.-K. S. Hong, R. Chaturvedi, M. B. Piazuelo et al., “Increased expression and cellular localization of spermine oxidase in ulcerative colitis and relationship to disease activity,” Inflammatory Bowel Diseases, vol. 16, no. 9, pp. 1557–1566, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. C. V. Dang, “MYC on the path to cancer,” Cell, vol. 149, no. 1, pp. 22–35, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. G. S. Krasnov, A. A. Dmitriev, A. V. Snezhkina, and A. V. Kudryavtseva, “Deregulation of glycolysis in cancer: glyceraldehyde-3-phosphate dehydrogenase as a therapeutic target,” Expert Opinion on Therapeutic Targets, vol. 17, no. 6, pp. 681–693, 2013. View at Publisher · View at Google Scholar · View at Scopus
  57. G. S. Krasnov, A. A. Dmitriev, V. A. Lakunina, A. A. Kirpiy, and A. V. Kudryavtseva, “Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy,” Expert Opinion on Therapeutic Targets, vol. 17, no. 10, pp. 1221–1233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. C. V. Dang, A. Le, and P. Gao, “MYC-induced cancer cell energy metabolism and therapeutic opportunities,” Clinical Cancer Research, vol. 15, no. 21, pp. 6479–6483, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. R. Huber, D. Pietsch, T. Panterodt, and K. Brand, “Regulation of C/EBPβ and resulting functions in cells of the monocytic lineage,” Cellular Signalling, vol. 24, no. 6, pp. 1287–1296, 2012. View at Publisher · View at Google Scholar · View at Scopus
  60. S. M. Rahman, R. C. Janssen, M. Choudhury et al., “CCAAT/enhancer-binding protein β (C/EBPβ) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice,” The Journal of Biological Chemistry, vol. 287, no. 41, pp. 34349–34360, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. S. Natsuka, S. Akira, Y. Nishio et al., “Macrophage differentiation-specific expression of NF-IL6, a transcription factor for interleukin-6,” Blood, vol. 79, no. 2, pp. 460–466, 1992. View at Google Scholar · View at Scopus
  62. I. V. Davydov, P. H. Krammer, and M. Li-Weber, “Nuclear factor-IL6 activates the human IL-4 promoter in T cells,” The Journal of Immunology, vol. 155, no. 11, pp. 5273–5279, 1995. View at Google Scholar · View at Scopus
  63. T. B. van Dijk, B. Baltus, J. A. M. Raaijmakers, J.-W. J. Lammers, L. Koenderman, and R. P. De Groot, “A composite C/EBP binding site is essential for the activity of the promoter of the IL-3/IL-5/granulocyte-macrophage colony-stimulating factor receptor βc gene,” Journal of Immunology, vol. 163, no. 5, pp. 2674–2680, 1999. View at Google Scholar · View at Scopus
  64. P. Greenwel, S. Tanaka, D. Penkov et al., “Tumor necrosis factor alpha inhibits type I collagen synthesis through repressive CCAAT/enhancer-binding proteins,” Molecular and Cellular Biology, vol. 20, no. 3, pp. 912–918, 2000. View at Publisher · View at Google Scholar · View at Scopus
  65. H. Kawagoe, A. Kandilci, T. A. Kranenburg, and G. C. Grosveld, “Overexpression of N-Myc rapidly causes acute myeloid leukemia in mice,” Cancer Research, vol. 67, no. 22, pp. 10677–10685, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. M. M. van Noesel, R. Pieters, P. A. Voûte, and R. Versteeg, “The N-myc paradox: N-myc overexpression in neuroblastomas is associated with sensitivity as well as resistance to apoptosis,” Cancer Letters, vol. 197, no. 1-2, pp. 165–172, 2003. View at Publisher · View at Google Scholar · View at Scopus
  67. A. C. Goodwin, S. Jadallah, A. Toubaji et al., “Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues,” Prostate, vol. 68, no. 7, pp. 766–772, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Cervelli, G. Bellavia, E. Fratini et al., “Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm,” BMC Cancer, vol. 10, article 555, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. S. L. Nowotarski, P. M. Woster, and R. A. Casero Jr., “Polyamines and cancer: implications for chemotherapy and chemoprevention,” Expert Reviews in Molecular Medicine, vol. 15, article e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. W. Wang, L. Q. Liu, and C. M. Higuchi, “Mucosal polyamine measurements and colorectal cancer risk,” Journal of Cellular Biochemistry, vol. 63, no. 2, pp. 252–257, 1996. View at Publisher · View at Google Scholar · View at Scopus
  71. N. Babbar, T. Murray-Stewart, and R. A. Casero Jr., “Inflammation and polyamine catabolism: the good, the bad and the ugly,” Biochemical Society Transactions, vol. 35, no. 2, pp. 300–304, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. C. S. Coleman, G. Hu, and A. E. Pegg, “Putrescine biosynthesis in mammalian tissues,” Biochemical Journal, vol. 379, no. 3, pp. 849–855, 2004. View at Publisher · View at Google Scholar · View at Scopus
  73. C. W. Tabor and H. Tabor, “Polyamines,” Annual Review of Biochemistry, vol. 53, pp. 749–790, 1983. View at Google Scholar · View at Scopus
  74. N. Babbar and E. W. Gerner, “Targeting polyamines and inflammation for cancer prevention,” Recent Results in Cancer Research, vol. 188, pp. 49–64, 2011. View at Publisher · View at Google Scholar · View at Scopus
  75. E. Galea, S. Regunathan, V. Eliopoulos, D. L. Feinstein, and D. J. Reis, “Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine,” Biochemical Journal, vol. 316, part 1, pp. 247–249, 1996. View at Publisher · View at Google Scholar · View at Scopus
  76. S. K. Mistry, T. J. Burwell, R. M. Chambers et al., “Cloning of human agmatinase. An alternate path for polyamine synthesis induced in liver by hepatitis B virus,” American Journal of Physiology—Gastrointestinal and Liver Physiology, vol. 282, no. 2, pp. G375–G381, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. C. J. Alteri, S. N. Smith, and H. L. T. Mobley, “Fitness of Escherichia coliduring urinary tract infection requires gluconeogenesis and the TCA cycle,” PLoS Pathogens, vol. 5, no. 5, Article ID e1000448, 2009. View at Publisher · View at Google Scholar · View at Scopus
  78. R. A. Casero Jr., Y. Wang, T. M. Stewart et al., “The role of polyamine catabolism in anti-tumour drug response,” Biochemical Society Transactions, vol. 31, no. 2, pp. 361–365, 2003. View at Publisher · View at Google Scholar · View at Scopus
  79. A. E. Pegg, “Spermidine/spermine-N1-acetyltransferase: a key metabolic regulator,” American Journal of Physiology—Endocrinology and Metabolism, vol. 294, no. 6, pp. E995–E1010, 2008. View at Publisher · View at Google Scholar · View at Scopus
  80. M. Morada, L. Pendyala, G. Wu, S. Merali, and N. Yarlett, “Cryptosporidium parvum induces an endoplasmic stress response in the intestinal adenocarcinoma HCT-8 cell line,” The Journal of Biological Chemistry, vol. 288, no. 42, pp. 30356–30364, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. N. Babbar, A. Hacker, Y. Huang, and R. A. Casero Jr., “Tumor necrosis factor α induces spermidine/spermine N 1-acetyltransferase through nuclear factor κB in non-small cell lung cancer cells,” Journal of Biological Chemistry, vol. 281, no. 34, pp. 24182–24192, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. N. Babbar, E. W. Gerner, and R. A. Casero Jr., “Induction of spermidine/spermine N1-acetyltransferase (SSAT) by aspirin in Caco-2 colon cancer cells,” Biochemical Journal, vol. 394, no. 1, pp. 317–324, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. O. A. Smirnova, M. G. Isaguliants, M. T. Hyvonen et al., “Chemically induced oxidative stress increases polyamine levels by activating the transcription of ornithine decarboxylase and spermidine/spermine- N1-acetyltransferase in human hepatoma HUH7 cells,” Biochimie, vol. 94, no. 9, pp. 1876–1883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  84. M. V. Ruiz-Pérez, M. Á. Medina, J. L. Urdiales, T. A. Keinänen, and F. Sánchez-Jiménez, “Polyamine metabolism is sensitive to glycolysis inhibition in human neuroblastoma cells,” The Journal of Biological Chemistry, vol. 290, no. 10, pp. 6106–6119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  85. E. A. Paz, J. Garcia-Huidobro, and N. A. Ignatenko, “Polyamines in cancer,” Advances in Clinical Chemistry, vol. 54, pp. 45–70, 2011. View at Publisher · View at Google Scholar · View at Scopus
  86. R. V. Iyengar, C. A. Pawlik, E. J. Krull et al., “Use of a modified ornithine decarboxylase promoter to achieve efficient c-MYC- or N-MYC-regulated protein expression,” Cancer Research, vol. 61, no. 7, pp. 3045–3052, 2001. View at Google Scholar · View at Scopus
  87. T. P. Forshell, S. Rimpi, and J. A. Nilsson, “Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthase,” Cancer Prevention Research, vol. 3, no. 2, pp. 140–147, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. D. Marinkovic, T. Marinkovic, E. Kokai, T. Barth, P. Möller, and T. Wirth, “Identification of novel Myc target genes with a potential role in lymphomagenesis,” Nucleic Acids Research, vol. 32, no. 18, pp. 5368–5378, 2004. View at Publisher · View at Google Scholar · View at Scopus
  89. A. J. Wagner, C. Meyers, L. A. Laimins, and N. Hay, “c-Myc induces the expression and activity of ornithine decarboxylase,” Cell Growth and Differentiation, vol. 4, no. 11, pp. 879–884, 1993. View at Google Scholar · View at Scopus
  90. R. Chaturvedi, Y. Cheng, M. Asim et al., “Induction of polyamine oxidase 1 by Helicobacter pylori causes macrophage apoptosis by hydrogen peroxide release and mitochondrial membrane depolarization,” The Journal of Biological Chemistry, vol. 279, no. 38, pp. 40161–40173, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. A. Hughes, N. I. Smith, and H. M. Wallace, “Polyamines reverse non-steroidal anti-inflammatory drug-induced toxicity in human colorectal cancer cells,” Biochemical Journal, vol. 374, no. 2, pp. 481–488, 2003. View at Publisher · View at Google Scholar · View at Scopus
  92. F. L. Meyskens Jr., C. E. McLaren, D. Pelot et al., “Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial,” Cancer Prevention Research, vol. 1, no. 1, pp. 32–38, 2008. View at Publisher · View at Google Scholar · View at Scopus
  93. T. Ben-Yosef, O. Yanuka, D. Halle, and N. Benvenisty, “Involvement of Myc targets in c-myc and N-myc induced human tumors,” Oncogene, vol. 17, no. 2, pp. 165–171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  94. M. H. Park, “The post-translational synthesis of a polyamine-derived amino acid, hypusine, in the eukaryotic translation initiation factor 5A (eIF5A),” Journal of Biochemistry, vol. 139, no. 2, pp. 161–169, 2006. View at Publisher · View at Google Scholar · View at Scopus
  95. P. C. Fernandez, S. R. Frank, L. Wang et al., “Genomic targets of the human c-Myc protein,” Genes and Development, vol. 17, no. 9, pp. 1115–1129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  96. E. W. Gerner, “Cancer chemoprevention locks onto a new polyamine metabolic target,” Cancer Prevention Research, vol. 3, no. 2, pp. 125–127, 2010. View at Publisher · View at Google Scholar · View at Scopus
  97. Q.-B. Meng, W.-M. Kang, J.-C. Yu et al., “Overexpression of eukaryotic translation initiation factor 5A2 (EIF5A2) correlates with cell aggressiveness and poor survival in gastric cancer,” PLoS ONE, vol. 10, no. 3, Article ID e0119229, 2015. View at Publisher · View at Google Scholar · View at Scopus
  98. W. Zhu, M.-Y. Cai, Z.-T. Tong et al., “Overexpression of EIF5A2 promotes colorectal carcinoma cell aggressiveness by upregulating MTA1 through C-myc to induce epithelial-mesenchymaltransition,” Gut, vol. 61, no. 4, pp. 562–575, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. A. B. Roos, J. L. Barton, A. Miller-Larsson et al., “Lung epithelial-C/EBPβ contributes to LPS-induced inflammation and its suppression by formoterol,” Biochemical and Biophysical Research Communications, vol. 423, no. 1, pp. 134–139, 2012. View at Publisher · View at Google Scholar · View at Scopus
  100. R. Chinery, J. A. Brockman, D. T. Dransfield, and R. J. Coffey, “Antioxidant-induced nuclear translocation of CCAAT/enhancer-binding protein β. A critical role for protein kinase A-mediated phosphorylation of Ser299,” The Journal of Biological Chemistry, vol. 272, no. 48, pp. 30356–30361, 1997. View at Publisher · View at Google Scholar · View at Scopus
  101. W. H. Brooks, “Increased polyamines alter chromatin and stabilize autoantigens in autoimmune diseases,” Frontiers in Immunology, vol. 4, article 91, 2013. View at Publisher · View at Google Scholar · View at Scopus
  102. M. Sauter, B. Moffatt, M. C. Saechao, R. Hell, and M. Wirtz, “Methionine salvage and S-adenosylmethionine: essential links between sulfur, ethylene and polyamine biosynthesis,” Biochemical Journal, vol. 451, no. 2, pp. 145–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  103. S. C. Lu and J. M. Mato, “S-adenosylmethionine in liver health, injury, and cancer,” Physiological Reviews, vol. 92, no. 4, pp. 1515–1542, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. J. R. Sufrin, S. Finckbeiner, and C. M. Oliver, “Marine-derived metabolites of S-adenosylmethionine as templates for new anti-infectives,” Marine Drugs, vol. 7, no. 3, pp. 401–434, 2009. View at Publisher · View at Google Scholar · View at Scopus